+39 02 00 660 300
+39 02 00 660 216
Antonio Lanzavecchia is known for his work on antigen presentation, T cell activation, immunological memory and human monoclonal antibodies. Lanzavecchia obtained a medical degree from the University of Pavia, where he specialized in paediatrics and in infectious diseases. Since 1983 he works in Switzerland, first as a scientific member of the Basel Institute for Immunology and since 2000 as the founding director of the Institute for Research in Biomedicine in Bellinzona. Lanzavecchia has been professor of Immunology at the University of Genova and Siena and at the Swiss Federal Institute of technology, ETH Zürich. He is member of the EMBO, fellow of the Royal College of Physicians and is honorary member of the American Society for Immunology, of the Swiss Society of Immunology and of the Swiss Academy of Medical Sciences. In 2016 he has been elected as international member of the U.S. National Academy of Sciences. He received the EMBO gold Medal, the Cloetta prize, the Robert Koch prize, the Sanofi-Institut Pasteur prize and the Louis-Jeantet Prize for Medicine. Lanzavecchia is the scientific Founder of Humabs Biomed, now a subsidiary of Vir Biotecnology and is currently senior Research fellow at Vir Biotecnology. His academic research continues at the INGM.